Latest news with #stockreport
Washington Post
22-05-2025
- Business
- Washington Post
EPlus: Fiscal Q4 Earnings Snapshot
HERNDON, Va. — HERNDON, Va. — EPlus Inc. (PLUS) on Thursday reported net income of $25.2 million in its fiscal fourth quarter. On a per-share basis, the Herndon, Virginia-based company said it had profit of 95 cents. Earnings, adjusted for non-recurring costs and stock option expense, were $1.11 per share. The computer products reseller posted revenue of $498.1 million in the period. For the year, the company reported profit of $108 million, or $4.05 per share. Revenue was reported as $2.07 billion. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on PLUS at
Washington Post
20-05-2025
- Business
- Washington Post
Daily Journal: Fiscal Q2 Earnings Snapshot
LOS ANGELES — LOS ANGELES — Daily Journal Corp. (DJCO) on Tuesday reported profit of $44.7 million in its fiscal second quarter. On a per-share basis, the Los Angeles-based company said it had profit of $32.43. The newspaper publisher posted revenue of $18.2 million in the period. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on DJCO at
Yahoo
19-05-2025
- Automotive
- Yahoo
At AU$17.77, Is Eagers Automotive Limited (ASX:APE) Worth Looking At Closely?
Eagers Automotive Limited (ASX:APE), might not be a large cap stock, but it saw a significant share price rise of 43% in the past couple of months on the ASX. The company is inching closer to its yearly highs following the recent share price climb. With many analysts covering the mid-cap stock, we may expect any price-sensitive announcements have already been factored into the stock's share price. However, what if the stock is still a bargain? Let's take a look at Eagers Automotive's outlook and value based on the most recent financial data to see if the opportunity still exists. Our free stock report includes 4 warning signs investors should be aware of before investing in Eagers Automotive. Read for free now. The stock seems fairly valued at the moment according to our valuation model. It's trading around 12% below our intrinsic value, which means if you buy Eagers Automotive today, you'd be paying a fair price for it. And if you believe that the stock is really worth A$20.13, then there's not much of an upside to gain from mispricing. In addition to this, Eagers Automotive has a low beta, which suggests its share price is less volatile than the wider market. View our latest analysis for Eagers Automotive Future outlook is an important aspect when you're looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. With profit expected to grow by 53% over the next couple of years, the future seems bright for Eagers Automotive. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation. Are you a shareholder? APE's optimistic future growth appears to have been factored into the current share price, with shares trading around its fair value. However, there are also other important factors which we haven't considered today, such as the financial strength of the company. Have these factors changed since the last time you looked at the stock? Will you have enough conviction to buy should the price fluctuates below the true value? Are you a potential investor? If you've been keeping tabs on APE, now may not be the most optimal time to buy, given it is trading around its fair value. However, the optimistic prospect is encouraging for the company, which means it's worth diving deeper into other factors such as the strength of its balance sheet, in order to take advantage of the next price drop. In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. To that end, you should learn about the 4 warning signs we've spotted with Eagers Automotive (including 1 which is a bit unpleasant). If you are no longer interested in Eagers Automotive, you can use our free platform to see our list of over 50 other stocks with a high growth potential. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
17-05-2025
- Business
- Yahoo
SBC Medical Group Holdings First Quarter 2025 Earnings: EPS: US$0.21 (vs US$2.36 in 1Q 2024)
Revenue: US$47.3m (down 14% from 1Q 2024). Net income: US$21.5m (up 15% from 1Q 2024). Profit margin: 45% (up from 34% in 1Q 2024). The increase in margin was driven by lower expenses. EPS: US$0.21. Our free stock report includes 2 warning signs investors should be aware of before investing in SBC Medical Group Holdings. Read for free now. All figures shown in the chart above are for the trailing 12 month (TTM) period Looking ahead, revenue is forecast to grow 6.3% p.a. on average during the next 2 years, compared to a 6.8% growth forecast for the Healthcare industry in the US. Performance of the American Healthcare industry. The company's shares are up 2.1% from a week ago. You should learn about the 2 warning signs we've spotted with SBC Medical Group Holdings (including 1 which is potentially serious). Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
17-05-2025
- Business
- Yahoo
An Intrinsic Calculation For Südzucker AG (ETR:SZU) Suggests It's 46% Undervalued
Südzucker's estimated fair value is €21.04 based on 2 Stage Free Cash Flow to Equity Current share price of €11.42 suggests Südzucker is potentially 46% undervalued Our fair value estimate is 90% higher than Südzucker's analyst price target of €11.08 Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Südzucker AG (ETR:SZU) as an investment opportunity by estimating the company's future cash flows and discounting them to their present value. One way to achieve this is by employing the Discounted Cash Flow (DCF) model. Believe it or not, it's not too difficult to follow, as you'll see from our example! Companies can be valued in a lot of ways, so we would point out that a DCF is not perfect for every situation. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model. Our free stock report includes 4 warning signs investors should be aware of before investing in Südzucker. Read for free now. We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. To begin with, we have to get estimates of the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years. Generally we assume that a dollar today is more valuable than a dollar in the future, so we need to discount the sum of these future cash flows to arrive at a present value estimate: 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 Levered FCF (€, Millions) €350.0m €207.0m €269.0m €214.2m €184.3m €166.9m €156.5m €150.1m €146.3m €144.2m Growth Rate Estimate Source Analyst x3 Analyst x2 Analyst x2 Est @ -20.38% Est @ -13.94% Est @ -9.43% Est @ -6.27% Est @ -4.06% Est @ -2.52% Est @ -1.44% Present Value (€, Millions) Discounted @ 4.6% €335 €189 €235 €179 €147 €128 €114 €105 €97.8 €92.2 ("Est" = FCF growth rate estimated by Simply Wall St)Present Value of 10-year Cash Flow (PVCF) = €1.6b The second stage is also known as Terminal Value, this is the business's cash flow after the first stage. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 1.1%. We discount the terminal cash flows to today's value at a cost of equity of 4.6%. Terminal Value (TV)= FCF2034 × (1 + g) ÷ (r – g) = €144m× (1 + 1.1%) ÷ (4.6%– 1.1%) = €4.2b Present Value of Terminal Value (PVTV)= TV / (1 + r)10= €4.2b÷ ( 1 + 4.6%)10= €2.7b The total value is the sum of cash flows for the next ten years plus the discounted terminal value, which results in the Total Equity Value, which in this case is €4.3b. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Relative to the current share price of €11.4, the company appears quite good value at a 46% discount to where the stock price trades currently. Remember though, that this is just an approximate valuation, and like any complex formula - garbage in, garbage out. Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. You don't have to agree with these inputs, I recommend redoing the calculations yourself and playing with them. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Südzucker as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 4.6%, which is based on a levered beta of 0.805. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business. Check out our latest analysis for Südzucker Strength Debt is well covered by earnings and cashflows. Weakness Earnings declined over the past year. Dividend is low compared to the top 25% of dividend payers in the Food market. Opportunity Annual earnings are forecast to grow faster than the German market. Good value based on P/E ratio and estimated fair value. Threat Dividends are not covered by earnings. Annual revenue is expected to decline over the next 4 years. Valuation is only one side of the coin in terms of building your investment thesis, and it is only one of many factors that you need to assess for a company. The DCF model is not a perfect stock valuation tool. Instead the best use for a DCF model is to test certain assumptions and theories to see if they would lead to the company being undervalued or overvalued. If a company grows at a different rate, or if its cost of equity or risk free rate changes sharply, the output can look very different. Why is the intrinsic value higher than the current share price? For Südzucker, we've put together three fundamental items you should further examine: Risks: Every company has them, and we've spotted 4 warning signs for Südzucker you should know about. Future Earnings: How does SZU's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart. Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing! PS. Simply Wall St updates its DCF calculation for every German stock every day, so if you want to find the intrinsic value of any other stock just search here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
